Start
Completion

Effects of Dimethyltryptamine in Healthy Subjects

CompletedRegisteredCTG

Double-blind, placebo-controlled 5-period crossover HV study (n=31) testing four intravenous DMT infusion schedules (total doses 0, 54, 69, 90, 115 mg) to characterise subjective and autonomic effects.

Details

This randomised, quadruple-blind, five-period crossover study in healthy volunteers compares four intravenous DMT administration schemes and placebo using a bolus and maintenance perfusion model to produce a stable, prolonged DMT experience.

Primary aims are to test dose–response relationships and to compare bolus-plus-perfusion versus perfusion-only schedules on pharmacokinetic, subjective and autonomic outcomes; safety and tolerability are systematically recorded.

Topics:Healthy Volunteers

Registry

Registry linkNCT04353024